New India Drug Price Caps Narrowed To Three Options
This article was originally published in PharmAsia News
Executive Summary
Indian price regulators are considering three types of maximum charges for two-thirds of pharmaceuticals not already controlled. One possibility is to cap the trade margin at 300 percent of the manufacturer's price instead of the current 2,900 percent. Another option considered is setting the cap at 50 percent or 70 percent of the leading brand in each category, an option opposed by the National Pharmaceutical Pricing Authority. A third option would set the top price at 15 percent of the printed maximum retail price, 35 percent for retailers. (Click here for more